Cohort Study of Intrauterine Diseases
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18-80
SponsorWenwen Wang
About this trial
"This study employs a prospective cohort design by establishing a uterine cavity diseases research platform. The investigators will collect participants' current medical history, menstrual and obstetric history, past medical history, physical and gynecological examinations, imaging studies, laboratory tests, and pathological examinations. After the hysteroscopic surgery, the investigators will conduct a one-year follow-up on the disease progression of the participants. Through this comprehensive approach, the investigators aim to deeply investigate the pathogenesis, risk factors, and optimized treatment strategies for uterine cavity diseases."
Eligibility criteria
Qualifiers
Age: 18-80 years;
Patients requiring hysteroscopy or diagnostic curettage for intrauterine pathologies (e.g., endometrial hyperplasia, endometrial polyps, submucosal uterine fibroids, adenomyosis, or endometrial malignancies);
Willing and able to comply with follow-up requirements;
Signed informed consent obtained.
Disqualifiers
Concurrent participation in other drug clinical trials;
Contraindications to or inability to tolerate hysteroscopy/curettage procedures;
Unwilling or unable to provide informed consent;
Unwilling or unable to adhere to study protocols.
Trial design
Treatments tested in this trial
- No intervention (observational study)
Treatment groups
2,000 Participants
are divided into 1 treatment groupSponsors and collaborators
Wenwen Wang
Lead sponsor
Tongji Hospital
Sponsor institution
Source ClinicalTrials.gov